SCHEMBL6615768

SCHEMBL6615768

COc1ccc(C[C](C)C)c(C)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.42
HSD17B10 Q99714 1/20 0.42
KMT2A Q03164 2/20 0.42
MEN1 O00255 1/20 0.42
APLNR P35414 1/20 0.42
KDM1A O60341 1/20 0.41
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
ALDH1A1 P00352 2/20 0.40
POLB P06746 1/20 0.40
HPGD P15428 1/20 0.39
APOBEC3A P31941 1/20 0.39
APOBEC3G Q9HC16 1/20 0.39
ESR1 P03372 1/20 0.39
CYP19A1 P11511 1/20 0.39
ESR2 Q92731 1/20 0.39
PTGS1 P23219 1/20 0.39
AKR1C3 P42330 1/20 0.39
AKR1C2 P52895 1/20 0.39
KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1922374 0.85 CYP3A4 (0.49) HTTHSD17B10KMT2AMEN1MAOA
SCHEMBL6619999 0.85 HSD17B10 (0.46) HTTHSD17B10APLNRPTGS1AKR1C3
SCHEMBL4664847 0.81 HSD17B10 (0.65) HTTHSD17B10KMT2AMEN1POLB
SCHEMBL8965127 0.81 HTT (0.41) HTTHSD17B10KMT2AMEN1APLNR
SCHEMBL3027059 0.81 APLNR (0.59) HSD17B10KMT2AMEN1APLNRALDH1A1
SCHEMBL3918324 0.80 ALDH1A1 (0.54) HTTHSD17B10KMT2AMEN1APLNR
SCHEMBL3127408 0.80 ALDH1A1 (0.47) HTTHSD17B10KMT2AMEN1APLNR
SCHEMBL11295684 0.79 GPR84 (0.47) HTTKMT2AMEN1APLNRKDM1A
SCHEMBL9917312 0.78 KMT2A (0.48) HTTKMT2AMEN1APLNRKDM1A
SCHEMBL1690285 0.78 HTT (0.46) HTTHSD17B10KMT2AMEN1APLNR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1418916-A1 2-AMINO-4-HETEROARYLAMINOPYRIMIDINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER Amgen Inc. (US) 2004-05-19 EP disclosed
WO-2003018022-A1 2-AMINO-4-HETEROARYLAMINOPYRIMIDINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER AMGEN INC. (US) 2003-03-06 WO disclosed